New Jersey

NJ Assembly committee approves biosimilar substitution bill

NJ Assembly committee approves biosimilar substitution bill

By Zachary Brennan

Under the bill first proposed in 2014, which won unanimous approval last week from a New Jersey Assembly committee, pharmacists would have to notify prescribers within five days of dispensing an interchangeable biosimilar.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers